| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $42.0B | $41.0B | $39.3B | $36.6B | $35.7B | $10.2B | $8.7B | $8.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $1.1B | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B | $1.0B | $0.8B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.5B | $4.4B | $2.5B | $3.6B | $5.7B | $1.2B | $1.1B | $0.9B |
| Net Income | $4.2B | $4.2B | $2.1B | $4.9B | $7.0B | $0.3B | $-0.4B | $0.4B |
| EPS (Basic) | $29.14 | $28.39 | $13.57 | $31.61 | $43.70 | $1.98 | $-2.43 | $2.07 |
| EPS (Diluted) | $29.08 | $28.34 | $13.53 | $31.47 | $43.54 | $1.97 | $-2.43 | $2.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $51.4B | $49.4B | $46.5B | $43.8B | $42.6B | $44.5B | $41.1B | $37.7B |
| Current Assets | $15.3B | $14.3B | $13.7B | $12.5B | $12.4B | $15.3B | $10.7B | $9.7B |
| Cash & Equivalents | $4.4B | — | $3.1B | $2.6B | $3.5B | $4.9B | $2.2B | $1.6B |
| Total Liabilities | $34.7B | $34.1B | $31.7B | $28.4B | $29.7B | $33.9B | $32.3B | $29.5B |
| Current Liabilities | $13.9B | $14.1B | $11.9B | $11.6B | $9.5B | $9.6B | $9.4B | $8.3B |
| Stockholders' Equity | $16.7B | $15.3B | $14.8B | $15.3B | $12.9B | $10.6B | $8.8B | $8.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.8B | $4.4B | $3.9B | $2.9B | $3.6B | $4.3B | $4.3B | $3.8B |
| Investing Cash Flow | $-1.2B | $-1.7B | $-1.6B | $-1.2B | $2.1B | $-1.2B | $-1.2B | $-8.9B |
| Capital Expenditures | $1.4B | $1.8B | $1.8B | $1.4B | $1.4B | $1.4B | $1.3B | $1.2B |
| Financing Cash Flow | $-3.6B | $-1.4B | $-1.8B | $-2.6B | $-7.0B | $-0.4B | $-2.4B | $-4.6B |